Fortitude Family Office’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-97
Closed -$527 2139
2025
Q2
$527 Buy
+97
New +$484 ﹤0.01% 1785

Other funds holding THRD

Fortitude Family Office's THRD Position: Q3 2025 in Review

Fortitude Family Office sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 97 shares — an estimated $527 sold.

Fortitude Family Office first reported a position in THRD in Q2 2025 and held it in 1 quarter. The position peaked at $527 in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Fortitude Family Office reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Fortitude Family Office sold 97 Third Harmonic Bio shares in Q3 2025, an estimated $527.
  • Fortitude Family Office first reported a position in Third Harmonic Bio in Q2 2025 and held it in 1 quarter.
  • Fortitude Family Office's Third Harmonic Bio position peaked at $527 in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Fortitude Family Office's 13F filing for Q3 2025, filed 17 Oct 2025.